PRKCD and colonic neoplasm: Previous studies have shown that HDAC inhibitor-induced differentiation is PKCδ-dependent in colon cancer cells [17], and that PKCδ enhances the differentiation and accelerates the apoptosis in PKCδ-overexpressing colon cancer CaCo-2 cells [22].